These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 16932284)

  • 1. Bezafibrate reduces the incidence of type 2 diabetes mellitus in patients with obesity.
    Miller M
    Nat Clin Pract Endocrinol Metab; 2006 Apr; 2(4):198-9. PubMed ID: 16932284
    [No Abstract]   [Full Text] [Related]  

  • 2. Peroxisome proliferator-activated receptor ligand bezafibrate for prevention of type 2 diabetes mellitus in patients with coronary artery disease.
    Tenenbaum A; Motro M; Fisman EZ; Schwammenthal E; Adler Y; Goldenberg I; Leor J; Boyko V; Mandelzweig L; Behar S
    Circulation; 2004 May; 109(18):2197-202. PubMed ID: 15123532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of bezafibrate on incidence of type 2 diabetes mellitus in obese patients.
    Tenenbaum A; Motro M; Fisman EZ; Adler Y; Shemesh J; Tanne D; Leor J; Boyko V; Schwammenthal E; Behar S
    Eur Heart J; 2005 Oct; 26(19):2032-8. PubMed ID: 15872029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial).
    Goldenberg I; Benderly M; Sidi R; Boyko V; Tenenbaum A; Tanne D; Behar S
    Am J Cardiol; 2009 Jan; 103(1):41-5. PubMed ID: 19101227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term benefit of high-density lipoprotein cholesterol-raising therapy with bezafibrate: 16-year mortality follow-up of the bezafibrate infarction prevention trial.
    Goldenberg I; Boyko V; Tennenbaum A; Tanne D; Behar S; Guetta V
    Arch Intern Med; 2009 Mar; 169(5):508-14. PubMed ID: 19273782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bezafibrate and serum amyloid A--low-density lipoprotein complex in patients with type 2 diabetes mellitus and hypertriglyceridemia.
    Kotani K; Satoh N; Yamada T
    Eur J Intern Med; 2010 Apr; 21(2):e10. PubMed ID: 20206863
    [No Abstract]   [Full Text] [Related]  

  • 7. [BECAIT [Bezafibrate Coronary Atherosclerosis Intervention Trial]].
    Yoshino G; Hirano T; Kazumi T
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():433-5. PubMed ID: 11347109
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy and tolerance of 400 MG bezafibrate in diabetic and hyperlipidaemic patients.
    Lakatos J; Molnár M; Tóth K
    Acta Physiol Hung; 1996; 84(4):433-5. PubMed ID: 9328624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secondary prevention with bezafibrate therapy for the treatment of dyslipidemia: an extended follow-up of the BIP trial.
    Goldenberg I; Benderly M; Goldbourt U;
    J Am Coll Cardiol; 2008 Jan; 51(4):459-65. PubMed ID: 18222357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postprandial chylomicrons and adipose tissue lipoprotein lipase are altered in type 2 diabetes independently of obesity and whole-body insulin resistance.
    Annuzzi G; Giacco R; Patti L; Di Marino L; De Natale C; Costabile G; Marra M; Santangelo C; Masella R; Rivellese AA
    Nutr Metab Cardiovasc Dis; 2008 Oct; 18(8):531-8. PubMed ID: 18321693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poor functional status based on the New York Heart Association classification exposes the coronary patient to an elevated risk of ischemic stroke.
    Koren-Morag N; Goldbourt U; Tanne D
    Am Heart J; 2008 Mar; 155(3):515-20. PubMed ID: 18294489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of lipid changes among type 2 diabetes patients in Sudan.
    Elnasri HA; Ahmed AM
    East Mediterr Health J; 2008; 14(2):314-24. PubMed ID: 18561723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Higher HDL cholesterol levels are associated with a lower incidence of chronic kidney disease in patients with type 2 diabetes.
    Zoppini G; Targher G; Chonchol M; Perrone F; Lippi G; Muggeo M
    Nutr Metab Cardiovasc Dis; 2009 Oct; 19(8):580-6. PubMed ID: 19196499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of bezafibrate in patients with combined hyperlipidemia].
    Vílchez Joya R; Escobar Jiménez F; Campos MM; Torres E; Orduña R; Cabrera J; Núñez J
    Med Clin (Barc); 1986 Feb; 86(5):190-4. PubMed ID: 3959651
    [No Abstract]   [Full Text] [Related]  

  • 15. C-reactive protein, bezafibrate, and recurrent coronary events in patients with chronic coronary heart disease.
    Haim M; Benderly M; Tanne D; Matas Z; Boyko V; Fisman EZ; Tenenbaum A; Zimmlichman R; Battler A; Goldbourt U; Behar S
    Am Heart J; 2007 Dec; 154(6):1095-101. PubMed ID: 18035081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of metformin on the incidence of type 2 diabetes mellitus and cardiovascular disease risk factors in overweight and obese subjects--the Carmos study.
    Andreadis EA; Katsanou PM; Georgiopoulos DX; Tsourous GI; Yfanti GK; Gouveri ET; Diamantopoulos EJ
    Exp Clin Endocrinol Diabetes; 2009 Apr; 117(4):175-80. PubMed ID: 19053032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multitherapy for diabetes.
    Vos E
    CMAJ; 2006 Nov; 175(10):1246-7; author reply 1247. PubMed ID: 17098957
    [No Abstract]   [Full Text] [Related]  

  • 18. Is a history of gestational diabetes related to risk factors for coronary heart disease?
    King KB; Gerich JE; Guzick DS; King KU; McDermott MP
    Res Nurs Health; 2009 Jun; 32(3):298-306. PubMed ID: 19274765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence, incidence, predictors and outcome of type 2 diabetes in Turkey.
    Onat A; Hergenç G; Uyarel H; Can G; Ozhan H
    Anadolu Kardiyol Derg; 2006 Dec; 6(4):314-21. PubMed ID: 17162275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of obesity on incidence of type 2 diabetes declines with age among Japanese women.
    Fujita M; Ueno K; Hata A
    Exp Biol Med (Maywood); 2009 Jul; 234(7):750-7. PubMed ID: 19429850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.